Sequent Scientific is India’s leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.
Financial Results:
Sequent Scientific Ltd reported Revenues for Q4FY24 of ₹361.20 Crores down from ₹366.67 Crore year on year, a fall of 1.49%.
Total Expenses for Q4FY24 of ₹357.85 Crores down from ₹395.62 Crores year on year, a fall of 9.55%.
Consolidated Net Profit of ₹1.28 Crores from -₹92.44 Crores in the same quarter of the previous year.
The Earnings per Share is -₹0.04, from -₹3.75 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.